Immunological consequences of HIV infection: advantage of being low responder casts doubts on vaccine development.
Immunosuppression in AIDS might be due to the immune response rather than to the pathogenicity of the virus. The basis of the immunosuppression could be molecular mimicries involving viral gp-110, CD4 molecules, antibodies, and CD4-acceptor sites. Whether an individual develops auto-immunosuppressive responses or mounts a harmless defence against (or coexists with) the virus follows the general rules of lymphocyte repertoire selection. MHC and V region genes and other polymorphic loci, together with the previous state of the immune system, particularly at early developmental periods, are factors that influence the response. Vaccination against gp 110-HIV might thus protect against infection but at the same time cause auto-immunosuppression and disease.
D000163:Acquired Immunodeficiency Syndrome / Q000276:immunology* / Q000517:prevention & control; D000914:Antibodies, Viral / Q000276:immunology; D000939:Epitopes / Q000235:genetics; D005814:Genes, Viral; D006678:HIV / Q000235:genetics / Q000276:immunology*; D015483:HIV Antibodies; D006801:Humans; D007165:Immunosuppression Therapy; D011991:Receptors, Virus / Q000276:immunology; D013601:T-Lymphocytes / Q000276:immunology; D014759:Viral Envelope Proteins / Q000276:immunology; D014765:Viral Vaccines / Q000302:isolation & purification*
D000914:Antibodies, Viral; D000939:Epitopes; D015483:HIV Antibodies; D011991:Receptors, Virus; D014759:Viral Envelope Proteins; D014765:Viral Vaccines